Brief: Lisata Therapeutics Receives $2.2 Million Of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program
20/04/2023 13:35
April 20 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS RECEIVES $2.2 MILLION OF NON-DILUTIVE
CAPITAL THROUGH NEW JERSEY TECHNOLOGY BUSINESS TAX CERTIFICATE
TRANSFER PROGRAM
Source text for Eikon: ID:nGNX4dRbFY
Further company coverage: LSTA.O
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco